title: Chlorambucil in indolent mantle cell lymphoma--just another old drug for a new disease?
authors.affiliation: Department of Internal Medicine III, University of Munich Campus Großhadern, Munich 81377, Germany. martin.dreyling@med.uni-muenchen.de
authors.forename: Martin
authors.initials: M
authors.lastname: Dreyling
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
authors.forename: Tamar
authors.initials: T
authors.lastname: Tadmor
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D002699:Chlorambucil / Q000008:administration & dosage / Q000627:therapeutic use*; D018450:Disease Progression; D004334:Drug Administration Schedule; D058492:Drug Repositioning; D004358:Drug Therapy / Q000379:methods / Q000592:standards / Q000639:trends; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000401:mortality; D020522:Lymphoma, Mantle-Cell / Q000145:classification / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D016019:Survival Analysis
chemical_list: D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D002699:Chlorambucil; D011241:Prednisone